Market Overview:
The global pharmaceutical drugs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for generic drugs. By type, the global pharmaceutical drugs market is segmented into brand drugs and generic drug. The brand drug segment is expected to account for a larger share of the global pharmaceuticals drugs market in 2018.
Product Definition:
Pharmaceutical drugs are medications that are prescribed by doctors to treat various illnesses. They can be used to cure diseases, alleviate symptoms, or prevent infections. Pharmaceutical drugs play a vital role in modern medicine and are responsible for saving countless lives each year.
Brand Drugs:
The brand drugs are the ones that have a name or registered trademark attached to it. The pharmaceutical industry has seen an increase in demand for branded drugs as compared to generic medicines due to their increased efficacy and better quality control measures. Also, there is an increase in the number of branded drug products available for consumption which has led many companies with competitive rivalry leading to higher demand and price competition.
Generic Drug:
A generic drug is a pharmaceutical product that has an active ingredient similar to that of a branded drug but is not the exact same. The generic version of the active ingredient can be approved by the FDA and sold in the U.S. after compliance with federal regulations, unlike patented drugs where no other company besides the original developer can produce its equivalent.
The demand for generic drugs has grown due to price consciousnessness among consumers, increased competition from local players,.
Application Insights:
The other application segment held around 69.0% of the global revenue share in 2017. Other applications include research, education and training institutions, manufacturing companies and others. The growth of this segment can be attributed to the growing demand for generic drugs in various applications across the globe owing to their cheaper cost as compared to brand-name drugs.
The hospital application segment is expected register a CAGR of XX% from 2018 to 2030 on account of increasing government expenditure towards building hospitals that will provide better healthcare facilities at lower costs which is likely to attract more patients leading toward higher consumption rates over the forecast period especially in developing countries like India, China.
Regional Analysis:
Asia Pacific is expected to be the fastest growing regional market with a CAGR of XX% over the forecast period. The growth can be attributed to rising healthcare expenditure, increasing patient awareness about available treatment options, and government initiatives for generic drugs manufacturing in the region. For instance, India’s Ministry of Health & Family Welfare has introduced new regulations that will allow 100% foreign direct investment (FDI) in pharmaceuticals through automatic route i.e., “automatic route under 50% FDI limit†without any prior approval from Government of India for investing up to USD X billion per year in this sector over a period of five years from 2017-18 fiscal year till 2019-20 fiscal year.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for effective and affordable pharmaceutical drugs to treat these conditions.
- Technological advancements in drug discovery and development: Pharmaceutical companies are making significant investments in research and development to develop innovative drugs that can effectively treat various chronic diseases. This has led to several technological advancements in the field of drug discovery and development, which is benefiting the overall pharmaceutical drugs market growth.
- Rising geriatric population: The global geriatric population is growing at a rapid pace due to improvements in healthcare facilities and lifestyle changes among older people across the world. This is leading to an increase in demand for various types of pharmaceutical drugs, especially those meant for treating age-related disorders such as Alzheimer’s disease, dementia, etcetera .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Drugs Market Research Report
By Type
Brand Drugs, Generic Drug
By Application
Hospital, Clinic, Other
By Companies
Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, Pfizer, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Allergan, Takeda, Boehringer Ingelheim, Takeda
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Drugs Market Report Segments:
The global Pharmaceutical Drugs market is segmented on the basis of:
Types
Brand Drugs, Generic Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Roche
- Sanofi
- Johnson & Johnson
- Merck & Co. (MSD)
- Novartis
- AbbVie
- Gilead Sciences
- GlaxoSmithKline (GSK)
- Amgen
- Pfizer
- Bristol-Myers Squibb
- Eli Lilly
- Teva
- Bayer
- Novo Nordisk
- Allergan
- Takeda
- Boehringer Ingelheim
- Takeda
Highlights of The Pharmaceutical Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Brand Drugs
- Generic Drug
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical drugs are medications that are intended to cure, prevent, or treat a disease.
Some of the major players in the pharmaceutical drugs market are Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, Pfizer, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Allergan, Takeda, Boehringer Ingelheim, Takeda.
The pharmaceutical drugs market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Drugs Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Pharmaceutical Drugs Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Pharmaceutical Drugs Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Pharmaceutical Drugs Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Pharmaceutical Drugs Market Size & Forecast, 2020-2028 4.5.1 Pharmaceutical Drugs Market Size and Y-o-Y Growth 4.5.2 Pharmaceutical Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Brand Drugs
5.2.2 Generic Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Brand Drugs
9.6.2 Generic Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Brand Drugs
10.6.2 Generic Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Brand Drugs
11.6.2 Generic Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Brand Drugs
12.6.2 Generic Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Brand Drugs
13.6.2 Generic Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Drugs Market: Competitive Dashboard
14.2 Global Pharmaceutical Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Roche
14.3.3 Sanofi
14.3.4 Johnson & Johnson
14.3.5 Merck & Co. (MSD)
14.3.6 Novartis
14.3.7 AbbVie
14.3.8 Gilead Sciences
14.3.9 GlaxoSmithKline (GSK)
14.3.10 Amgen
14.3.11 Pfizer
14.3.12 Bristol-Myers Squibb
14.3.13 Eli Lilly
14.3.14 Teva
14.3.15 Bayer
14.3.16 Novo Nordisk
14.3.17 Allergan
14.3.18 Takeda
14.3.19 Boehringer Ingelheim
14.3.20 Takeda